HM-2002

N/A

Report date: 2026/04/16 20:00:17
First In Class

Base Information

Drug NameHM-2002
Drug Alias NameHM-2002HM2002
ClassificationBiologicsSmall molecules > Nucleosides and nucleotide derivtives > Circular RNA
Mechanisms of ActionVascular endothelial growth factor stimulants
TargetsVascular endothelial growth factor
Therapy Area/IndicationsChronic Coronary SyndromeAngina PectorisMyocardial Ischemia +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesCircode Biomed
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesCircode Biomed
Inactive CompaniesN/A
Active IndicationsChronic Coronary SyndromeAngina PectorisMyocardial Ischemia +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A